Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 122

1.

Serotonin toxicity caused by the interaction of fentanyl and serotonergic medications.

Armitage MC, Woolfield KI, Page CB.

Emerg Med Australas. 2016 Feb;28(1):119-20. doi: 10.1111/1742-6723.12521. Epub 2015 Dec 17. No abstract available.

PMID:
26679218
2.

Myenteric expression of nerve growth factor and the p75 neurotrophin receptor regulate axonal remodeling as a consequence of colonic inflammation in mice.

Petrie CN, Armitage MN, Kawaja MD.

Exp Neurol. 2015 Sep;271:228-40. doi: 10.1016/j.expneurol.2015.06.010. Epub 2015 Jun 11.

PMID:
26073142
3.

Activated adult microglia influence retinal progenitor cell proliferation and differentiation toward recoverin-expressing neuron-like cells in a co-culture model.

Xu Y, Balasubramaniam B, Copland DA, Liu J, Armitage MJ, Dick AD.

Graefes Arch Clin Exp Ophthalmol. 2015 Jul;253(7):1085-96. doi: 10.1007/s00417-015-2961-y. Epub 2015 Feb 14.

PMID:
25680876
4.

Regulatory and clinical considerations for biosimilar oncology drugs.

Bennett CL, Chen B, Hermanson T, Wyatt MD, Schulz RM, Georgantopoulos P, Kessler S, Raisch DW, Qureshi ZP, Lu ZK, Love BL, Noxon V, Bobolts L, Armitage M, Bian J, Ray P, Ablin RJ, Hrushesky WJ, Macdougall IC, Sartor O, Armitage JO.

Lancet Oncol. 2014 Dec;15(13):e594-605. doi: 10.1016/S1470-2045(14)70365-1. Epub 2014 Nov 24. Review.

5.

Calibration and validation of the 2WIN photoscreener compared to the PlusoptiX S12 and the SPOT.

Kirk S, Armitage MD, Dunn S, Arnold RW.

J Pediatr Ophthalmol Strabismus. 2014 Sep-Oct;51(5):289-92. doi: 10.3928/01913913-20140701-01. Epub 2014 Jul 8.

PMID:
25000209
6.

Impact of month of birth on the development of autoimmune thyroid disease in the United Kingdom and Europe.

Hamilton A, Newby PR, Carr-Smith JD, Disanto G, Allahabadia A, Armitage M, Brix TH, Chatterjee K, Connell JM, Hegedüs L, Hunt PJ, Lazarus JH, Pearce SH, Robinson BG, Taylor JC, Vaidya B, Wass JA, Wiersinga WM, Weetman AP, Ramagopalan SV, Franklyn JA, Gough SC, Simmonds MJ.

J Clin Endocrinol Metab. 2014 Aug;99(8):E1459-65. doi: 10.1210/jc.2014-1270. Epub 2014 May 19.

PMID:
24840812
7.

Atropine vs patching for treatment of moderate amblyopia: follow-up at 15 years of age of a randomized clinical trial.

Repka MX, Kraker RT, Holmes JM, Summers AI, Glaser SR, Barnhardt CN, Tien DR; Pediatric Eye Disease Investigator Group.

JAMA Ophthalmol. 2014 Jul;132(7):799-805. doi: 10.1001/jamaophthalmol.2014.392.

8.

Performance of four new photoscreeners on pediatric patients with high risk amblyopia.

Arnold RW, Armitage MD.

J Pediatr Ophthalmol Strabismus. 2014 Jan-Feb;51(1):46-52. doi: 10.3928/01913913-20131223-02. Epub 2014 Jan 3.

PMID:
24369683
9.

Pediatric photoscreeners in high risk patients 2012: a comparison study of Plusoptix, Iscreen and SPOT.

Arnold RW, Arnold AW, Armitage MD, Shen JM, Hepler TE, Woodard TL.

Binocul Vis Strabolog Q Simms Romano. 2013;28(1):20-8.

PMID:
23521032
10.

Soft sheets of fibrillar bone from a fossil of the supraorbital horn of the dinosaur Triceratops horridus.

Armitage MH, Anderson KL.

Acta Histochem. 2013 Jul;115(6):603-8. doi: 10.1016/j.acthis.2013.01.001. Epub 2013 Feb 13.

PMID:
23414624
11.

Predictive value from pediatrician plusoptix screening: impact of refraction and binocular alignment.

Arnold RW, Tulip D, McArthur E, Shen J, Tappel J, Arnold LE, Winkle E, Armitage MD.

Binocul Vis Strabolog Q Simms Romano. 2012;27(4):227-32.

PMID:
23234483
12.

Stereoacuity in children with anisometropic amblyopia.

Wallace DK, Lazar EL, Melia M, Birch EE, Holmes JM, Hopkins KB, Kraker RT, Kulp MT, Pang Y, Repka MX, Tamkins SM, Weise KK; Pediatric Eye Disease Investigator Group.

J AAPOS. 2011 Oct;15(5):455-61. doi: 10.1016/j.jaapos.2011.06.007.

13.

An anatomic, computed tomographic assessment of the coracoid process with special reference to the congruent-arc latarjet procedure.

Armitage MS, Elkinson I, Giles JW, Athwal GS.

Arthroscopy. 2011 Nov;27(11):1485-9. doi: 10.1016/j.arthro.2011.06.020. Epub 2011 Sep 15.

PMID:
21924857
14.

Subtrochanteric insufficiency fractures associated with bisphosphonate use: 2 case reports and review.

Kearse J, Armitage M, Suk M, Berrey BH.

Geriatr Orthop Surg Rehabil. 2011 May;2(3):105-9. doi: 10.1177/2151458511413764.

15.

Quantitative muscle hardness as a noninvasive means for detecting patients at risk of compartment syndromes.

Steinberg B, Riel R, Armitage M, Berrey H.

Physiol Meas. 2011 Apr;32(4):433-44. doi: 10.1088/0967-3334/32/4/005. Epub 2011 Mar 8.

PMID:
21383493
16.

A single generic multi-source feedback tool for revalidation of all UK career-grade doctors: does one size fit all?

Mackillop LH, Crossley J, Vivekananda-Schmidt P, Wade W, Armitage M.

Med Teach. 2011;33(2):e75-83. doi: 10.3109/0142159X.2010.535870.

PMID:
21275537
17.

Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial.

Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group, Armitage J, Bowman L, Wallendszus K, Bulbulia R, Rahimi K, Haynes R, Parish S, Peto R, Collins R.

Lancet. 2010 Nov 13;376(9753):1658-69. doi: 10.1016/S0140-6736(10)60310-8. Epub 2010 Nov 8. Erratum in: Lancet. 2011 Jan 8;377(9760):126.

18.

Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration.

Kleinschnitz C, Grund H, Wingler K, Armitage ME, Jones E, Mittal M, Barit D, Schwarz T, Geis C, Kraft P, Barthel K, Schuhmann MK, Herrmann AM, Meuth SG, Stoll G, Meurer S, Schrewe A, Becker L, Gailus-Durner V, Fuchs H, Klopstock T, de Angelis MH, Jandeleit-Dahm K, Shah AM, Weissmann N, Schmidt HH.

PLoS Biol. 2010 Sep 21;8(9). pii: e1000479. doi: 10.1371/journal.pbio.1000479.

19.

Comparative pharmacology of chemically distinct NADPH oxidase inhibitors.

Wind S, Beuerlein K, Eucker T, Müller H, Scheurer P, Armitage ME, Ho H, Schmidt HH, Wingler K.

Br J Pharmacol. 2010 Oct;161(4):885-98. doi: 10.1111/j.1476-5381.2010.00920.x.

20.

Diagnosis and individual treatment of cardiovascular diseases: targeting vascular oxidative stress.

Armitage ME, La M, Schmidt HH, Wingler K.

Expert Rev Clin Pharmacol. 2010 Sep;3(5):639-48. doi: 10.1586/ecp.10.40.

PMID:
22111746
Items per page

Supplemental Content

Loading ...
Write to the Help Desk